President Donald Trump has announced that large pharmaceutical company Regeneron has signed a new and extensive drug pricing agreement, as part of the administration's initiative to lower the cost of drugs for Americans. Regeneron will cut the price of its cholesterol-lowering treatment Praluent to $225, down from $537, for patients buying on the TrumpRx website, according to a White House fact sheet on the announcement . It also means that any new medicines manufactured by Regeneron will

Tag-uri: Donald Trump